INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED FILES APPLICATION FOR "COMBINATION TREATMENT FOR MULTIPLE MYELOMA WITH BELANTAMAB MAFODOTIN AND DEXAMETHASONE TOGETHER WITH LENALIDOMIDE, POMALIDOMIDE, BORTEZOMIB, OR CARFILZOMIB, OR WITH LENALIDOMIDE AND BORTEZOMIB"

GENEVA, May 13 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/IB2025/061180) for "COMBINATION TREATMENT FOR MULTIPLE MYELOMA WITH BELANTAMAB MAFODOTIN AND DEXAMETHASONE TOGETHER WITH LENALIDOMIDE, POMALIDOMIDE, BORTEZOMIB, OR CARFILZOMIB, OR WITH LENALIDOMIDE AND BORTEZOMIB" on Nov 03, 2025. With publication no. WO/2026/094004, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KREMER, Brandon (1250 South Collegevi...